These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37751397)

  • 1. Assessment of treatment response on facial vitiligo, a step forward. But what about the neck?
    Eleftheriadou V; Seneschal J
    Br J Dermatol; 2023 Dec; 190(1):5-6. PubMed ID: 37751397
    [No Abstract]   [Full Text] [Related]  

  • 2. Two Rare Cases of Facial Vitiligo-Like Hypopigmentation With Upper Dermal Elastic Fibers Degeneration.
    Hou X; Su T; Su Z; Zhang C; Lin L; Lu Y
    Am J Dermatopathol; 2021 Nov; 43(11):846-848. PubMed ID: 33899767
    [No Abstract]   [Full Text] [Related]  

  • 3. Bimatoprost ophthalmic solution in facial vitiligo.
    Jha AK; Prasad S; Sinha R
    J Cosmet Dermatol; 2018 Jun; 17(3):437-440. PubMed ID: 29034590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototherapy with PUVA: Versatility and efficacy in dermatoses.
    França TF; Diniz AV; Silva ILD; Carvalho RRPC; Lopes VK; Zanuncio VV
    Rev Assoc Med Bras (1992); 2017 May; 63(5):393-396. PubMed ID: 28724034
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index.
    Bae JM; Zubair R; Ju HJ; Kohli I; Lee HN; Eun SH; Lyons AB; Vellaichamy G; Han TY; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2022 Feb; 86(2):387-393. PubMed ID: 34246695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: Need for early treatment in vitiligo.
    Lee DY; Kim CR; Lee JH; Yang JM
    J Dermatol; 2010 Dec; 37(12):1057-9. PubMed ID: 21083711
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo.
    Mayoral FA; Vega JM; Stavisky H; McCormick CL; Parneix-Spake A
    J Drugs Dermatol; 2007 May; 6(5):517-21. PubMed ID: 17679186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood facial vitiligo: how intractable is it?
    Kim SA; Cho S; Kwon SH; Park JT; Na JI; Huh CH; Park KC
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):713-8. PubMed ID: 25174801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of facial vitiligo: A cluster analysis of 473 patients.
    Bae JM; Jung YS; Jung HM; Park JH; Hann SK
    Pigment Cell Melanoma Res; 2018 Sep; 31(5):585-591. PubMed ID: 29509997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
    McKesey J; Pandya AG
    J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study.
    Seneschal J; Duplaine A; Maillard H; Passeron T; Andreu N; Lassalle R; Favary C; Droitcourt C; Taïeb A; Ezzedine K
    J Invest Dermatol; 2021 Jul; 141(7):1728-1734. PubMed ID: 33549606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation of leukotrichia in vitiligo with transplantation of cultured autologous melanocytes.
    Yao L; Zhong SX; Hu DN; Guo JW; Li SS; Xie XL; Song Y
    Int J Dermatol; 2014 Aug; 53(8):1016-8. PubMed ID: 23557445
    [No Abstract]   [Full Text] [Related]  

  • 13. Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.
    van Geel N; Desmedt V; De Schepper S; Boone B; Lapeere H; Speeckaert R
    Br J Dermatol; 2016 Apr; 174(4):922-4. PubMed ID: 26556484
    [No Abstract]   [Full Text] [Related]  

  • 14. Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
    Br J Dermatol; 2023 Oct; 189(5):e94. PubMed ID: 37879743
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
    Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
    Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band.
    Castanedo-Cazares JP; Lepe V; Moncada B
    Photodermatol Photoimmunol Photomed; 2003 Feb; 19(1):35-6. PubMed ID: 12713553
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitiliginous lesions induced by amyl nitrite exposure.
    Vine K; Meulener M; Shieh S; Silverberg NB
    Cutis; 2013 Mar; 91(3):129-36. PubMed ID: 23617083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo.
    Merhi R; Canu D; Barnetche T; Duchez E; Gey A; Andreu N; Taieb A; Boniface K; Seneschal J
    Br J Dermatol; 2022 Sep; 187(3):422-424. PubMed ID: 35289925
    [No Abstract]   [Full Text] [Related]  

  • 20. Repigmentation of vitiligo with pimecrolimus cream: a case report.
    Mayoral FA; Gonzalez C; Shah NS; Arciniegas C
    Dermatology; 2003; 207(3):322-3. PubMed ID: 14571079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.